A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients With Primary Generalized Tonic-Clonic Seizures
Latest Information Update: 24 Aug 2023
Price :
$35 *
At a glance
- Drugs Lamotrigine (Primary)
- Indications Tonic-clonic epilepsy
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 23 Jan 2018 Results assessing the effect of Age-Related Factors on the PK of Lamotrigine and Potential Implications for Dose Optimisation in patients data obtained from NCT00043875, NCT00144872, NCT00113165, NCT00104416, NCT00516139, NCT00264615 published in the Clinical Pharmacokinetics
- 20 May 2009 Actual end date (1 Jul 2008) added as reported by ClinicalTrials.gov.
- 20 May 2009 Additional location Malaysia identified as reported by ClinicalTrials.gov.